 Now while current immunotherapies work only against cancers of the blood and bone marrow, the T-cells engineered by Northwestern and UCSF were able to kill tumors derived from skin, lung, and stomach in mice. The team has already begun working towards testing this new approach in human beings. There's been a lot of really cool advancements in cancer treatment lately.